Do persistent thyroid antibodies in Hashimoto’s thyroiditis reflect ongoing thyroid autoimmunity?

Hashimoto’s thyroiditis is a thyroid-directed autoimmune disorder in which antibodies to thyroid peroxidase (TPOAb) and thyroglobulin (TgAb) commonly coexist with immune-cell infiltration and thyroid structural injury.

Antibodies and current disease activity

• Persistent TPOAb and TgAb plausibly indicate sustained immune recognition of thyroid antigens. TPOAb is the more sensitive and clinically preferred serologic marker; TgAb can add support when TPOAb is absent despite compatible clinical findings.
• These antibodies are indirect markers, not real-time measures of thyroid inflammation, follicular destruction, or thyroid function. Persistent or changing titers should therefore not be used to monitor disease activity or determine treatment; TSH, with free T4 when indicated, is more clinically informative.

Tissue injury and biological mechanisms

• The link between thyroid autoimmunity and lymphocytic inflammation is well established. Hashimoto pathology characteristically shows dense lymphoplasmacytic infiltration, lymphoid follicles/germinal centers, colloid depletion, and follicular-cell destruction.
• Injury is primarily consistent with cellular immune mechanisms: thyroid-antigen–reactive T cells promote cytokine-mediated inflammation, while CD8+ cytotoxicity and Fas–FasL signaling can induce thyrocyte apoptosis. Thus, antibodies mark autoimmunity but do not alone establish that antibody-mediated injury is occurring at a given moment.
• Chronic inflammation and follicular loss can be followed by an atrophic gland and variable interstitial fibrosis.

Structural outcomes

• Fibrosis and atrophy are recognized outcomes but are heterogeneous rather than inevitable. Extensive fibrosis is especially associated with fibrous variants of Hashimoto thyroiditis.
• Smaller thyroid volume correlates with more pronounced hypothyroidism, but available longitudinal observations cannot cleanly separate autoimmune progression from baseline severity or levothyroxine-related effects.

Bottom line

• Persistent TPOAb/TgAb support, but do not quantify, ongoing thyroid-directed autoimmunity. The autoimmune process clearly can cause lymphocytic inflammation and follicular injury and may lead to fibrosis or atrophy over time, with substantial patient-to-patient variation.